Mouse N2a cells treated with elacridar (GF120918)
To investigate the mechanism underlying the anti-prion properties of elacridar, mouse N2a cells were treated with four concentrations of elacridar for 7 days: 0, 250, 700, and 2500 nM before RNA isolation and transcriptomic analysis.